Our CEO-CSO and COO were attending the last edition of Biofit in Marseille on December 12th and 13th.

DRUGABILIS presence on the AFSSI booth enabled numerous interactions with TTO/SATT reps, biotech team-leaders and complementary preclinical R&D service providers, sharing with them details about our pharmaceutical drugability service offer for early R&D during very valuable B2B meetings. Several of these fruitful exchanges are expected to lead to new collaborations in the coming year!

We want to thank the organizers and the attendees… and we’ll be glad to attend Biofit edition next year!

2023 edition key figures >